{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:33:54Z","timestamp":1793126034114,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107667","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:37:38Z","timestamp":1790033858000},"page":"107667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unconventional molecular descriptors for blood-brain barrier permeability prediction: a unified model and its implications for local anesthetic design, micellar formulation, and chelation-based effect modification"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-9062","authenticated-orcid":false,"given":"Onishi","family":"Tatsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107667_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2003.12.004","article-title":"The factors that influence permeation across the blood-brain barrier","volume":"39","author":"Abraham","year":"2004","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2026.107667_bib0002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/dmd.31.3.312","article-title":"P-glycoprotein limits the brain penetration of sedating but not non-sedating H1-antagonists","volume":"31","author":"Chen","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107667_bib0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/cn3001922","article-title":"Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein","volume":"4","author":"Dolghih","year":"2012","journal-title":"ACS. Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ejps.2026.107667_bib0004","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.0c00474","article-title":"Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer\u2019s disease, Parkinson\u2019s disease, and intracerebral hemorrhage","volume":"18","author":"Farr","year":"2021","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2026.107667_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002329900434","article-title":"Blood-brain barrier permeation: molecular parameters governing passive diffusion","volume":"165","author":"Fischer","year":"1998","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejps.2026.107667_bib0006","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","article-title":"Permeability of the blood-brain barrier: molecular mechanism of transport of drugs and physiologically important compounds","volume":"248","author":"Fong","year":"2015","journal-title":"J. Membr. Biol."},{"issue":"12","key":"10.1016\/j.ejps.2026.107667_bib0007","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3390\/pharmaceutics13122141","article-title":"Large-scale evaluation of collision cross sections to investigate blood-brain barrier permeation of drugs","volume":"13","author":"Guntner","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107667_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55856-7","article-title":"Collision cross sections obtained with ion mobility mass spectrometry as a new descriptor to predict blood-brain barrier permeation by drugs","volume":"9","author":"Guntner","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107667_bib0009","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1039\/D5TB01540E","article-title":"Nano-enabled delivery of anesthetics: mechanistic insights, technological advances and translational challenges","volume":"13","author":"Hu","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejps.2026.107667_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.111183","article-title":"Explaining blood-brain barrier permeability by synergistic effect on molecular substructures","volume":"198","author":"Lee","year":"2025","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejps.2026.107667_bib0011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.euroneuro.2007.06.003","article-title":"A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs","volume":"18","author":"Linnet","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.ejps.2026.107667_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107667_bib0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"Loscher","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejps.2026.107667_bib0014","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2147\/DDDT.S417051","article-title":"Recent research advances in nano-based drug delivery systems for local anesthetics","volume":"Volume 17","author":"Ma","year":"2023","journal-title":"Drug Des Devel Ther."},{"issue":"30","key":"10.1016\/j.ejps.2026.107667_bib0015","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1021\/acs.jpcb.4c01634","article-title":"Quantifying induced dipole effects in small molecule permeation in a model phospholipid bilayer","volume":"128","author":"Montgomery","year":"2024","journal-title":"J. Phys. Chem. B"},{"issue":"11","key":"10.1016\/j.ejps.2026.107667_bib0016","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.ejps.2026.107667_bib0017","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41570-023-00563-1","article-title":"Molecular chameleons in drug discovery","volume":"8","author":"Poongavanam","year":"2024","journal-title":"Nat. Rev. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2026.107667_bib0018","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejps.2026.107667_bib0019","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ejps.2026.107667_bib0020","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ejps.2026.107667_bib0021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12031-007-0055-y","article-title":"The role of size and charge for blood-brain barrier permeation of drugs and fatty acids","volume":"33","author":"Seelig","year":"2007","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.ejps.2026.107667_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1073\/pnas.91.1.68","article-title":"A method to determine the ability of drugs to diffuse through the blood-brain barrier","volume":"91","author":"Seelig","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\/2","key":"10.1016\/j.ejps.2026.107667_bib0023","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1504\/IJCBDD.2013.052195","article-title":"Analysing molecular polar surface descriptors to predict blood-brain barrier permeation","volume":"6","author":"Shityakov","year":"2013","journal-title":"Int. J. Comput. Biol. Drug Des."},{"issue":"6","key":"10.1016\/j.ejps.2026.107667_bib0024","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/acs.jcim.4c02212","article-title":"Enhancing blood-brain barrier penetration prediction by machine learning-based integration of novel and existing, in silico and experimental molecular parameters from a standardized database","volume":"65","author":"Spielvogel","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ejps.2026.107667_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/membranes13070623","article-title":"Chromatographic data in statistical analysis of blood-brain barrier permeability indices","volume":"13","author":"Wanat","year":"2023","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.ejps.2026.107667_bib0026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0702804","article-title":"The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-\/-) and mdr1a (+\/+) mice","volume":"128","author":"Xie","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107667_bib0027","article-title":"Delta PSA: a new metric for conformational dynamics underlying macrocyclic peptide permeability","author":"Yu","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejps.2026.107667_bib0028","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:53:11Z","timestamp":1793123591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S0928098726002411"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107667","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unconventional molecular descriptors for blood-brain barrier permeability prediction: a unified model and its implications for local anesthetic design, micellar formulation, and chelation-based effect modification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107667"}}